ID

14364

Beschreibung

Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICS; ODM derived from: https://clinicaltrials.gov/show/NCT00486343

Link

https://clinicaltrials.gov/show/NCT00486343

Stichworte

  1. 12.04.16 12.04.16 -
Rechteinhaber

CC BY-NC 3.0

Hochgeladen am

12. April 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Asthma NCT00486343

Eligibility Asthma NCT00486343

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00486343
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. male or female 12-70 years of age (inclusive).
Beschreibung

age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
2. diagnosis of asthma for at least 6 months.
Beschreibung

asthma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C0040223
3. morning fev1 of 40-80% normal.
Beschreibung

morning fev1

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0748133
UMLS CUI [1,2]
C0332170
4. demonstrated reversible airflow restriction.
Beschreibung

reversible airflow restriction

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1527303
UMLS CUI [1,2]
C0205343
5. non-smokers.
Beschreibung

non-smoker

Datentyp

boolean

Alias
UMLS CUI [1]
C0337672
6. on moderate doses of ics with inadequate asthma control.
Beschreibung

ics

Datentyp

boolean

Alias
UMLS CUI [1]
C3248292
7. signed icf
Beschreibung

signed icf

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. diagnosis of copd.
Beschreibung

copd

Datentyp

boolean

Alias
UMLS CUI [1]
C0024117
2. uncontrolled systemic illness.
Beschreibung

uncontrolled systemic illness

Datentyp

boolean

Alias
UMLS CUI [1]
C0009488
3. hypersensitivity to any component of zyflo cr
Beschreibung

hypersensitivity to any component of zyflo cr

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1951657
4. any patient with an unscheduled visit to an er or hospital for asthma exacerbation within past 3 months.
Beschreibung

asthma exacerbation with an unscheduled visit to an er or hospital

Datentyp

boolean

Alias
UMLS CUI [1]
C0349790
UMLS CUI [2]
C0040223
UMLS CUI [3]
C0583237
UMLS CUI [4]
C0019993
5. history of hepatitis or active liver disease.
Beschreibung

hepatitis or acute liver disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0019158
UMLS CUI [2]
C0023895
6. alt greater than 3xuln.
Beschreibung

ALT

Datentyp

boolean

Alias
UMLS CUI [1]
C0201836
7. history of hiv infection
Beschreibung

HIV

Datentyp

boolean

Alias
UMLS CUI [1]
C0019682
8. recent history of drug or alcohol abuse.
Beschreibung

history of drug or alcohol abuse

Datentyp

boolean

Alias
UMLS CUI [1]
C0038586
9. oral corticosteroids within one month, cromolyn sodium or nedocromil within 14 days, theophylline, laba, zyflo, or leukotriene modifiers, warfarin or propranolol, inhaled anti-cholinergics, or combination laba/ics.
Beschreibung

oral corticosteroids within one month, cromolyn sodium or nedocromil within 14 days, theophylline, laba, zyflo, or leukotriene modifiers, warfarin or propranolol, inhaled anti-cholinergics, or combination laba/ics

Datentyp

boolean

Alias
UMLS CUI [1]
C0001617
UMLS CUI [2]
C0012694
UMLS CUI [3]
C0068483
UMLS CUI [4]
C0039771
UMLS CUI [5]
C2936789
UMLS CUI [6]
C0595726
UMLS CUI [7]
C0724508
UMLS CUI [8]
C0043031
UMLS CUI [9]
C0033497
UMLS CUI [10]
C0354764
10. omalizumab within 3 months.
Beschreibung

omalizumab

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0966225
UMLS CUI [1,2]
C1514463
11. pregnant female.
Beschreibung

pregnancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
12. participation with 30 days in investigational study.
Beschreibung

participation with 30 days in investigational study

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568

Ähnliche Modelle

Eligibility Asthma NCT00486343

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00486343
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
1. male or female 12-70 years of age (inclusive).
boolean
C0001779 (UMLS CUI [1])
asthma
Item
2. diagnosis of asthma for at least 6 months.
boolean
C0004096 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
morning fev1
Item
3. morning fev1 of 40-80% normal.
boolean
C0748133 (UMLS CUI [1,1])
C0332170 (UMLS CUI [1,2])
reversible airflow restriction
Item
4. demonstrated reversible airflow restriction.
boolean
C1527303 (UMLS CUI [1,1])
C0205343 (UMLS CUI [1,2])
non-smoker
Item
5. non-smokers.
boolean
C0337672 (UMLS CUI [1])
ics
Item
6. on moderate doses of ics with inadequate asthma control.
boolean
C3248292 (UMLS CUI [1])
signed icf
Item
7. signed icf
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
copd
Item
1. diagnosis of copd.
boolean
C0024117 (UMLS CUI [1])
uncontrolled systemic illness
Item
2. uncontrolled systemic illness.
boolean
C0009488 (UMLS CUI [1])
hypersensitivity to any component of zyflo cr
Item
3. hypersensitivity to any component of zyflo cr
boolean
C0020517 (UMLS CUI [1,1])
C1951657 (UMLS CUI [1,2])
asthma exacerbation with an unscheduled visit to an er or hospital
Item
4. any patient with an unscheduled visit to an er or hospital for asthma exacerbation within past 3 months.
boolean
C0349790 (UMLS CUI [1])
C0040223 (UMLS CUI [2])
C0583237 (UMLS CUI [3])
C0019993 (UMLS CUI [4])
hepatitis or acute liver disease
Item
5. history of hepatitis or active liver disease.
boolean
C0019158 (UMLS CUI [1])
C0023895 (UMLS CUI [2])
ALT
Item
6. alt greater than 3xuln.
boolean
C0201836 (UMLS CUI [1])
HIV
Item
7. history of hiv infection
boolean
C0019682 (UMLS CUI [1])
history of drug or alcohol abuse
Item
8. recent history of drug or alcohol abuse.
boolean
C0038586 (UMLS CUI [1])
oral corticosteroids within one month, cromolyn sodium or nedocromil within 14 days, theophylline, laba, zyflo, or leukotriene modifiers, warfarin or propranolol, inhaled anti-cholinergics, or combination laba/ics
Item
9. oral corticosteroids within one month, cromolyn sodium or nedocromil within 14 days, theophylline, laba, zyflo, or leukotriene modifiers, warfarin or propranolol, inhaled anti-cholinergics, or combination laba/ics.
boolean
C0001617 (UMLS CUI [1])
C0012694 (UMLS CUI [2])
C0068483 (UMLS CUI [3])
C0039771 (UMLS CUI [4])
C2936789 (UMLS CUI [5])
C0595726 (UMLS CUI [6])
C0724508 (UMLS CUI [7])
C0043031 (UMLS CUI [8])
C0033497 (UMLS CUI [9])
C0354764 (UMLS CUI [10])
omalizumab
Item
10. omalizumab within 3 months.
boolean
C0966225 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
pregnancy
Item
11. pregnant female.
boolean
C0032961 (UMLS CUI [1])
participation with 30 days in investigational study
Item
12. participation with 30 days in investigational study.
boolean
C2348568 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video